<DOC>
	<DOC>NCT02215694</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of dual probiotic strains containing Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on triglyceride and apolipoprotein A-V.</brief_summary>
	<brief_title>Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels</brief_title>
	<detailed_description>A randomized, double-blind, placebo-controlled study was conducted on 128 nondiabetic and hypertriglyceridemic (Plasma Triglyceride, 150-500 mg/dL) subjects. Over a 12 week test period, the probiotic group consumed 2g of powder daily containing dual probiotic strains, while the placebo group consumed the same without probiotics.</detailed_description>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>nondiabetic (plasma fasting glucose, &lt;126mg/dL; 2hour plasma glucose, &lt;200mg/dL) borderline to moderate hypertriglyceridemia (plasma triglyceride, 150500 mg/dL) lipidlowering medications use any medications or supplement use any probiotics products use for the past 1 months dyslipidemia diabetes mellitus hypertension liver disease renal disease cardiovascular disease cerebrovascular disease pancreatitis cancer medication or alcohol abuse pregnant or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>24 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Apolipoprotein A-V</keyword>
	<keyword>LDL particle size</keyword>
	<keyword>probiotic</keyword>
	<keyword>triglyceride</keyword>
</DOC>